Press release
Tuberculosis Market Analysis: Insights into Novel and Emerging Pipeline Therapies, Epidemiology, Key Pharma Players, Clinical Trials, Growth Prospects, and Treatment Landscape | DelveInsight
(Albany, US) DelveInsight's "Tuberculosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Tuberculosis, historical and forecasted epidemiology as well as the Tuberculosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Click here to know more about Tuberculosis Market report offerings: https://www.delveinsight.com/report-store/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Tuberculosis Market Report:
1. Tuberculosis is caused by a group of closely related bacterial species termed Mycobacterium tuberculosis complex.
2. It is estimated that in the pre-antibiotic era, M. bovis was responsible for about 6% of tuberculosis deaths in humans.
3. Tuberculosis is one of the top three infectious killing diseases in the world: HIV/AIDS kills 3 million people each year, TB kills 2 million and malaria kills 1 million.
4. The global community woke up to this disease when, in 1993, WHO declared TB as a global emergency.
Key benefits of the Tuberculosis Market Report:
1. Tuberculosis market report covers a descriptive overview and comprehensive insight of the
Tuberculosis Epidemiology and Tuberculosis market in the 7MM (the United States, EU5
(Germany, Spain, France, Italy, UK) Japan.)
2. The Tuberculosis market report provides insights on the current and emerging therapies.
3. Tuberculosis market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Tuberculosis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Tuberculosis market.
Got queries? Click here to know more about the Tuberculosis Market Landscape: https://www.delveinsight.com/report-store/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Tuberculosis Overview
Tuberculosis (TB) is one of the most ancient diseases of mankind, with molecular evidence going back to over 17,000 years. In spite of newer modalities for diagnosis and treatment of TB, people are still suffering, and worldwide it is among the top 10 killer infectious diseases. According to the World Health Organization (WHO), TB is a worldwide pandemic. It is a leading cause of death among HIV-infected people.
Tuberculosis Market
The dynamics of the Tuberculosis market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as moxifloxacin, rifapentine, Linezolid
Bedaquiline and others during the forecasted period 2019-2032.
Learn more by requesting a sample @ Tuberculosis Market Landscape: https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Tuberculosis Pipeline Therapies and Key Companies
Tuberculosis Pipeline Therapies-
• AEC / BC02
• Linezolid
• Bedaquiline
• Cycloserine
• BCG-PPD
• WX-081
• And Others
Key Tuberculosis Companies-
• Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd
• Shanghai Jiatan Pharmatech Co., Ltd
• Macleods Pharmaceuticals
• Otsuka Pharmaceutical
• And Others
Click here to know more about all the Tuberculosis companies and therapies in the market: https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Tuberculosis Patient Share (%) Overview at a Glance
5. Tuberculosis Market Overview at a Glance
6. Tuberculosis Disease Background and Overview
7. Tuberculosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Tuberculosis
9. Tuberculosis Current Treatment and Medical Practices
10. Unmet Needs
11. Tuberculosis Emerging Therapies
12. Tuberculosis Market Outlook
13. Country-Wise Tuberculosis Market Analysis (2019-2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Tuberculosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Tuberculosis Market Outlook 2032: https://www.delveinsight.com/sample-request/tuberculosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
Adenoid Cystic Carcinoma Pipeline
https://www.delveinsight.com/report-store/adenoid-cystic-carcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
"Adenoid Cystic Carcinoma Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Adenoid Cystic Carcinoma market. A detailed picture of the Adenoid Cystic Carcinoma pipeline landscape is provided, which includes the disease overview and Adenoid Cystic Carcinoma treatment guidelines.
Adenoid Cystic Carcinoma Epidemiology
https://www.delveinsight.com/report-store/adenoid-cystic-carcinoma-acc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's 'Adenoid Cystic Carcinoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Adenoid Cystic Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diagnostic Imaging Equipment Market
https://www.delveinsight.com/report-store/diagnostic-imaging-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
https://www.delveinsight.com/report-store/invasive-candidiasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
"DelveInsight's 'Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's, "Filgrastim Biosimilar Insight, 2022," report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027
To know more about our Competitive Services, Click here:
https://www.delveinsight.com/consulting/competitive-intelligence-services?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tuberculosis Market Analysis: Insights into Novel and Emerging Pipeline Therapies, Epidemiology, Key Pharma Players, Clinical Trials, Growth Prospects, and Treatment Landscape | DelveInsight here
News-ID: 2715581 • Views: …
More Releases from DelveInsight Business Research

Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…

Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight O …
The Presbyopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Presbyopia pipeline products will significantly revolutionize the Presbyopia market dynamics.
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France,…

Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Idiopathic Pulmonary Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Idiopathic Pulmonary Fibrosis, offering comprehensive insights into the Idiopathic Pulmonary Fibrosis revenue trends,…

Myocardial Infarction Market Positioned for Accelerated Development Through 2034 …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast
https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…